Care By Design Cannabis Brand Logo

Care By Design

Data Snapshot: Jun 01, 2026
$500K+

May-2026

Sales

Neutral

Trend

6-Month

50

Product Count

SKUs

$37.32

Avg Price

-13.5%

YoY Sales Change

-2.4%

YoY Price Change

Established in 2014, Care By Design is a legacy cannabis company recognized for its CBD-rich product line that promotes a wellness-focused approach to cannabis consumption. Emphasizing the medicinal properties of cannabis, the brand offers potent CBD products, including 1:1 capsules and MAX drops, aiming to provide value and relief from occasional stress. The company has built its reputation in the California market for potency, specifically targeted to consumers with sensitivity towards THC.
Care By Design Sales

Market Insights Snapshot

Care By Design Historical Sales by Category

Care By Design’s mix in May 2026 remains anchored in Tincture & Sublingual at 51.46% share despite a year-over-year decline of 20.20% and a month-over-month uptick of 3.16%, while Vapor Pens has risen to 31.64% share with 8.54% year-over-year growth and a 2.53% month-over-month gain. Capsules hold 7.61% share with a 26.79% year-over-year decline contrasted by an 8.22% month-over-month increase, and Topical sits at 5.44% share with a 21.47% year-over-year decline alongside a 3.20% month-over-month rise; Edible is 3.86% share, down 17.47% year-over-year and 6.26% month-over-month. Average price dipped 2.41% year-over-year to $37.32 while the brand’s overall sales fell 13.52% year-over-year, and within the anchor category average price is $43.29 versus Vapor Pens at $35.10, indicating mix pressure from a lower-priced growth engine. The pattern implies the brand is gradually pivoting toward faster-growing inhalables while defending a shrinking but still dominant tincture base, creating a price-mix drag that offsets month-over-month volume stabilization.

In California, Care By Design holds rank 3 in Tincture & Sublingual, a position that coexists with a 20.20% year-over-year decline in that category and an 8.54% year-over-year increase in Vapor Pens share to 31.64%. The 3.16% month-over-month gain in Tincture & Sublingual alongside a 2.53% month-over-month rise in Vapor Pens, plus an 8.22% month-over-month lift in Capsules despite a 26.79% year-over-year drop, signals a near-term rebound concentrated in core and adjacent wellness formats while Edible’s 6.26% month-over-month decline and 17.47% year-over-year slide reduce breadth. With overall 24-month sales down 27.11% and average prices down 2.41% year-over-year, the brand’s positioning leans toward defending premium wellness leadership in tinctures (rank 3) while using Vapor Pens growth to sustain reach, accepting a lower-price mix that can win share but risks compressing revenue per unit unless premiumization in capsules/topicals regains traction.

May-2026 Rank
Capsules
Edible
Tincture & Sublingual
Topical
Vapor Pens
11
55
3
7
57
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
51.5%
$43.29
-20.2%
+3.2%
Vapor Pens
31.6%
$35.10
+8.5%
+2.5%
Capsules
7.6%
$51.91
-26.8%
+8.2%
Topical
5.4%
$39.48
-21.5%
+3.2%
Edible
3.9%
$12.65
-17.5%
-6.3%
Care By Design

Competitive Landscape

Care By Design holds rank #3 in CA Tincture & Sublingual for May 2026, unchanged from #3 year over year, and flat versus February 2026 at #3; this stability contrasts with Papa & Barkley sitting at #1 with a -13.3% year-over-year sales change and Yummi Karma at #2 with a -7.6% year-over-year decline, indicating Care By Design’s position is holding despite contraction among higher-ranked peers. Compared with VET CBD at #4 (unchanged year over year) and ABX / AbsoluteXtracts moving from #6 to #5, Care By Design’s lack of rank movement alongside a historical peak at #1 in February 2025 implies the brand is defending share but not converting top competitors’ declines into rank gains.

Care By Design market ranking for CA Tincture & Sublingual

Care By Design

Notable Products

CBD/THC 2:1 Higher THC Full Spectrum Cartridge (1g) posted the steepest decline at -25.5% month over month and sat at rank 10, while CBD/THC 4:1 Medium THC Full Spectrum Cartridge (1g) rose 20.4% to rank 2, indicating a split within the Vapor Pens lineup where higher-THC formats lost share as balanced ratios gained. CBD/THC 1:1 MAX Peppermint Full Spectrum Tincture (1000mg CBD, 1000mg THC, 15ml) held rank 1 with a 6.0% lift and $94,126 in May 2026 sales, as two additional Tincture & Sublingual SKUs occupied ranks 3 and 5 with +38.9% and -5.7%, concentrating three of the top five in tinctures. With Vapor Pens taking ranks 2, 6, 7, and 10 alongside mixed momentum, the pattern implies Care By Design is leaning into tincture-led stability while reallocating emphasis toward mid-ratio vape formulations over higher-THC variants.

Product
Category
Jan-2026
Feb-2026
Mar-2026
Apr-2026
May-2026
MoM %
CBD/THC 1:1 MAX Peppermint Full Spectrum Tincture (1000mg CBD, 1000mg THC, 15ml)
Tincture & Sublingual
1
1
1
1
1
+6.0%
CBD/THC 4:1 Medium THC Full Spectrum Cartridge (1g)
Vapor Pens
3
2
2
2
2
+20.4%
CBD/THC 40:1 Low THC Tincture (480mg CBD, 12mg THC, 15ml)
Tincture & Sublingual
6
7
7
8
3
+38.9%
CBD/THC 1:1 Raspberry Gummies 20-Pack (100mg CBD, 100mg THC)
Edible
2
3
4
4
4
+3.9%
CBD/THC 40:1 Lower THC Tincture (960 CBD, 24mg THC, 30ml)
Tincture & Sublingual
7
4
5
3
5
-5.7%
CBD/THC 18:1 Lower THC Full Spectrum Cartridge (1g)
Vapor Pens
4
6
3
5
6
-8.9%
CBD/THC 1:1 Higher THC Full Spectrum Cartridge (1g)
Vapor Pens
5
5
6
6
7
+5.4%
CBD/THC 1:1 Refresh Full Spectrum Drops (480mg CBD, 480mg THC, 30ml)
Tincture & Sublingual
>10
9
10
>10
8
CBD/THC 1:1 Refresh Full Spectrum Sublingual Tincture (240mg CBD, 60mg CBDA, 240mg THC, 60mg THCA, 15ml)
Tincture & Sublingual
>10
>10
>10
>10
9
CBD/THC 2:1 Higher THC Full Spectrum Cartridge (1g)
Vapor Pens
8
8
8
7
10
-25.5%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market